Top

Drug Safety

Published in:

01-10-2014 | Editorial

Pharmacovigilance for a Revolving World: Prospects of Patient-Generated Data on the Internet

Author: G. Niklas Norén

Published in: Drug Safety | Issue 10/2014

Excerpt

“The whole world turns upside down in 10 years, but you turn upside down with it” …

Via Flash mob gone wrong, Tom Scott 2010, http://www.youtube.com/watch?v=RyMdOT8YJgY.

The standard adopted for electronic transmission of Individual Case Safety Reports by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH).

Basch E. The missing voice of patients in drug-safety reporting. N Engl J Med. 2010;362(10):865–9.PubMedCrossRefPubMedCentral

Banerjee A, Okun S, Edwards IR, et al. Patient-reported outcome measures in safety event reporting: PROSPER consortium guidance. Drug Saf. 2013;36(12):1129–49.PubMedCrossRefPubMedCentral

Wicks P, Vaughan TE, Massagli MP, Heywood J. Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm. Nat Biotech. 2011;29(5):411–4.CrossRef

de Langen J, van Hunsel F, Passier A, den Berg L-V, van Grootheest K. Adverse drug reaction reporting by patients in The Netherlands: three years of experience. Drug Saf. 2008;31(6):515–24.PubMedCrossRef

Bergvall T, Norén GN, Lindquist M. vigiGrade: a tool to identify well-documented individual case reports and highlight systematic data quality issues. Drug Saf. 2014;37(1):65–77.PubMedCrossRef

Knezevic MZ, Bivolarevic IC, Peric TS, Jankovic SM. Using Facebook to increase spontaneous reporting of adverse drug reactions. Drug Saf. 2011;34(4):351–2.PubMedCrossRef

Edwards IR, Lindquist M. Social media and networks in pharmacovigilance: boon or bane? Drug Saf. 2011;34(4):267–71.PubMedCrossRef

Franzen W. Can social media benefit drug safety? Drug Saf. 2011;34(9):793.PubMedCrossRef

Freifeld CC, Brownstein JS, Menone CM, et al. Digital drug safety surveillance: monitoring pharmaceutical products in Twitter. Drug Saf. 2014;37(5):343–50.PubMedCrossRefPubMedCentral

10.

Chee BW, Berlin R, Schatz B. Predicting adverse drug events from personal health messages. AMIA Annu Symp Proc. 2011;2011:217–26.PubMedPubMedCentral

11.

White RW, Harpaz R, Shah NH, DuMouchel W, Horvitz E. Toward enhanced pharmacovigilance using patient-generated data on the internet. Clin Pharmacol Ther. 2014;96(2):239–46. doi:10.1038/clpt.2014.77.PubMedCrossRefPubMedCentral

12.

White RW, Tatonetti NP, Shah NH, Altman RB, Horvitz E. Web-scale pharmacovigilance: listening to signals from the crowd. J Am Med Inform Assoc. 2013;20(3):404–8.PubMedCrossRefPubMedCentral

13.

Norén GN, Hopstadius J, Bate A, Star K, Edwards IR. Temporal pattern discovery in longitudinal electronic patient records. Data Min Knowl Disc. 2010;20(3):361–87.CrossRef

14.

van Hunsel F, van der Welle C, Passier A, van Puijenbroek E, van Grootheest K. Motives for reporting adverse drug reactions by patient-reporters in The Netherlands. Eur J Clin Pharmacol. 2010;66(11):1143–50.PubMedCrossRefPubMedCentral

15.

Grajales F, Clifford D, Loupos P, et al. Social networking sites and the continuously learning health system: a survey: Institute of Medicine; 23 Jan 2014.

16.

Norén GN, Caster O, Juhlin K, Lindquist M. Zoo or Savannah? Choice of training ground for evidence-based pharmacovigilance. Drug Saf. Epub 9 Jul 2014. doi:10.1007/s40264-014-0198-z.

17.

Lazer D, Kennedy R, King G, Vespignani A. The parable of Google Flu: traps in big data analysis. Science. 2014;343(6176):1203–5.PubMedCrossRef

18.

Edwards IR. What are the real lessons from Vioxx? Drug Saf. 2005;28(8):651–8.PubMedCrossRef

19.

Ginsberg J, Mohebbi MH, Patel RS, Brammer L, Smolinski MS, Brilliant L. Detecting influenza epidemics using search engine query data. Nature. 2009;457(7232):1012–4.PubMedCrossRef

20.

Lindquist M. VigiBase, the WHO Global ICSR Database System: basic facts. Drug Inf J. 2008;42(5):409–19.

21.

Norén GN, Orre R, Bate A, Edwards IR. Duplicate detection in adverse drug reaction surveillance. Data Min Knowl Disc. 2007;14(3):305–28.CrossRef

Title: Pharmacovigilance for a Revolving World: Prospects of Patient-Generated Data on the Internet
Author: G. Niklas Norén
Publication date: 01-10-2014
Publisher: Springer International Publishing
Published in: Drug Safety / Issue 10/2014
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI: https://doi.org/10.1007/s40264-014-0205-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pharmacovigilance for a Revolving World: Prospects of Patient-Generated Data on the Internet

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2014

INTERNATIONAL SOCIETY OF PHARMACOVIGILANCE

The Safety of Olanzapine in Young Children: A Systematic Review and Meta-Analysis

Safety Profile of Dapagliflozin for Type 2 Diabetes: Pooled Analysis of Clinical Studies for Overall Safety and Rare Events

Comparison of Pregnancy and Lactation Labeling for Attention-Deficit Hyperactivity Disorder Drugs Marketed in Australia, the USA, Denmark, and the UK

Restrictive Reimbursement Policies: Bias Implications for Claims-Based Drug Safety Studies

Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum